Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test
Author(s) -
Laurent Dortet,
Rémy A. Bonnin,
Ivana Pennisi,
Lauraine Gauthier,
Agnès B. Jousset,
Laura Dabos,
R. Christopher D. Furniss,
Despoina A.I. Mavridou,
Pierre Bogaerts,
Y. Glupczynski,
Anaïs Potron,
Patrick Plésiat,
Racha Beyrouthy,
Frédéric Robin,
Richard Bonnet,
Thierry Naas,
Alain Filloux,
Gérald Larrouy-Maumus
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky330
Subject(s) - polymyxin , plasmid , escherichia coli , microbiology and biotechnology , enterobacteriaceae , biology , bacteria , polymyxin b , lipid a , chromosome , genetics , gene
Polymyxins are currently considered a last-resort treatment for infections caused by MDR Gram-negative bacteria. Recently, the emergence of carbapenemase-producing Enterobacteriaceae has accelerated the use of polymyxins in the clinic, resulting in an increase in polymyxin-resistant bacteria. Polymyxin resistance arises through modification of lipid A, such as the addition of phosphoethanolamine (pETN). The underlying mechanisms involve numerous chromosome-encoded genes or, more worryingly, a plasmid-encoded pETN transferase named MCR. Currently, detection of polymyxin resistance is difficult and time consuming.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom